| Breakdown | TTM | Feb 2025 | Feb 2024 | Feb 2023 | Feb 2022 | Feb 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 36.74B | 36.48B | 35.20B | 31.26B | 26.85B | 24.95B |
| Gross Profit | 12.24B | 11.89B | 11.46B | 10.48B | 8.81B | 7.57B |
| EBITDA | 1.46B | 1.33B | 1.71B | 1.82B | 1.54B | 1.10B |
| Net Income | 529.20M | 501.58M | 568.47M | 1.00B | 1.50B | 703.82M |
Balance Sheet | ||||||
| Total Assets | 13.88B | 13.45B | 12.44B | 10.96B | 9.39B | 8.24B |
| Cash, Cash Equivalents and Short-Term Investments | 2.23B | 2.90B | 2.86B | 2.48B | 1.76B | 2.04B |
| Total Debt | 4.53B | 3.73B | 3.50B | 2.30B | 1.87B | 1.89B |
| Total Liabilities | 7.88B | 7.31B | 6.63B | 5.36B | 4.50B | 4.67B |
| Stockholders Equity | 5.99B | 6.15B | 5.81B | 5.60B | 4.89B | 3.58B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 467.55M | -234.61M | 885.31M | 219.94M | 1.10B |
| Operating Cash Flow | 0.00 | 1.46B | 210.61M | 1.18B | 538.07M | 1.22B |
| Investing Cash Flow | 0.00 | -1.44B | -595.40M | -562.30M | -645.76M | -440.12M |
| Financing Cash Flow | 0.00 | 15.51M | 778.62M | 110.78M | -197.38M | -223.84M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥8.06B | 2.45 | ― | 2.66% | 15.17% | 12.30% | |
74 Outperform | ¥7.71B | -522.29 | ― | 2.05% | 13.52% | -42.59% | |
71 Outperform | ¥9.40B | 10.41 | ― | 2.70% | 7.21% | 411.30% | |
66 Neutral | ¥11.81B | 7.84 | ― | 0.30% | 5.03% | -17.66% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
45 Neutral | ¥7.54B | -28.99 | ― | ― | -4.54% | -261.55% | |
45 Neutral | ¥5.77B | 33.76 | ― | ― | -4.10% | ― |